In 2022, the largest Ukrainian pharmaceutical manufacturer Darnitsa launched the certification procedure in Australia under the GMP clearance procedure. After 11 months, Darnitsa was certified and shipped the first batch of medicines in Australia, according to the company's press service.
"Australia is a state with one of the most stringent regulations in the world. And the fact of registration and the start of shipments of our first drug to this continent confirms that Ukrainian manufacturers who have a GMP certificate can seriously compete with international giants," responsible for long-distance international registration and Darnitsa entering new markets Anna Pavlyuk-Gavrilova.
The export base of Darnitsa is medicines for cardiological and neurological diseases, anti-infectives and painkillers.
Anna added that the company's future plans include development in Southeast Asia, Africa and the EU. The 2nd 2 regions Darnitsa called the key ones for its development.
